Director, CHIEF EXECUTIVE OFFICER · Whitehawk Therapeutics, Inc. · Common Stock
Side
SELL
Value
$17K
Shares
5,100
Price
$3.31
Executed
Mar 2, 2026
Disclosed
Mar 10, 2026
Disclosure timeline8 days from execution to publication · legal deadline 2 business days
Mar 2 executedMar 10, 2026 disclosed
WHWK · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 6 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Lennon David James filed this Form 4 reporting a open-market sale of WHWK on Mar 2, 2026. It became public on Mar 10, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, CHIEF EXECUTIVE OFFICER
Lennon David Jamescik:0001995275
Issuer
Whitehawk Therapeutics, Inc.cik:0001422142
Revision history · 0
No field has changed since this record was first ingested.
